Rest of the World
Pubblicato il 11-09-2026 - MENARINI Group in Firenze
Overview
Reporting to: Corporate Oncology & RoW Controlling Manager
Key stakeholders: Corporate Finance, RoW Commercial, Supply Chain, Market Access, Legal, Business Development, distribution partners
The Rest of the World (RoW) Controller for Stemline Oncology Business is responsible for coordinating, controlling, and reporting the financial performance of international markets (excluding the US), ensuring accuracy, transparency, and robustness of financial data.This role provides strategic support to management, contributes to budgeting and forecasting processes, and coordinates financial activities with local partners, distributors, and the corporate team.
Main Activities & Responsibilities
Financial Planning & Reporting
- Manage Budget, Forecast, 5-Year Plan (5YP), and Monthly Closing processes for all RoW markets.
- Prepare monthly performance analyses (P&L;, commercial KPIs, Headcount KPIs), highlighting variances and key drivers.
- Consolidate results from various countries/partners, ensuring data quality and alignment with corporate guidelines.
- Support the preparation of the monthly business review with Senior Management and Global Finance.
Controlling & Business Partnering
- Monitor sales, royalties, milestones, operational costs, and investments in RoW markets.
- Manage financial relationships with distributors, affiliates, and local partners, ensuring reporting accuracy, compliance, and proper data transfer.
- Collaborate with Commercial, Market Access, Supply Chain, and Business Development teams to provide financial analyses supporting decision-making.
- Ensure correct application of transfer pricing policies and revenue recognition guidelines .
Operational Finance
- Ensure proper use of models, templates, and tools, suggesting improvements and automation where applicable.
- Support internal and external audits, ensuring compliance with corporate policies.
- Contribute to business cases, financial evaluations, scenario analysis, and ad hoc analyses.